People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Accentia Biopharmaceuticals Inc | — | Biotechnology | Pre-Seed | $775K | $20.7M | 2012 |
James A. McNulty at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James A. McNulty on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher C. Chapman | 1 | 3 |
| Carlos F. Santos | 1 | 2 |
| David M. Schubert | 1 | 2 |
| Samuel S. Duffey | 1 | 2 |
| Francis E. O'Donnell, Jr. | 1 | 1 |
| Douglas M. Calder | 1 | 1 |
| William S. Poole | 1 | 1 |
| Garrison J. Hasara | 1 | 1 |
| Edmund C. King | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.